'Phenomenal' pill slashes heart disease deaths by 22%
The clinical trial, which was conducted on 27,000 coronary or peripheral artery disease patients from 33 countries, has since been halted - 12 months early - because of the exciting results.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Clinical Trials | Health | Heart | Heart Disease | Peripheral Vascular Disease (PVD)